1. Home
  2. Medical News
  3. Cataract/Refractive Surgery

MetLife to Acquire Versant Health, Owner of Davis Vision and Superior Vision

09/17/2020

MetLife announced it has entered into a definitive agreement to acquire Versant Health from an investor group led by Centerbridge Partners and including FFL Partners for approximately $1.675 billion in an all-cash transaction. Versant Health owns the marketplace brands Davis Vision and Superior Vision.

The transaction will strengthen and differentiate MetLife’s vision benefit offering with one of the industry’s broadest networks of providers and plan options, according to a company news release. Following the acquisition, MetLife will gain access to Versant Health’s roughly 35 million members, and MetLife’s existing customers will gain access to Versant Health’s provider network, which is one of the largest in the industry.

“This transaction furthers our goal of deploying capital to the highest-value opportunities,” MetLife President and CEO Michel Khalaf, said in a company news release. “We are pleased to welcome Versant Health, a well-run and well-respected leader in vision care, to the MetLife family. In Versant, we have found the right strategic fit with our group benefits business. We expect this combination to accelerate revenue growth while delivering greater value for our customers and shareholders.”

MetLife is a market leader in the U.S. Group Benefits space with an estimated market share of 15 percent. MetLife’s Group Benefits business offers over 35 group products and services—the most in the industry—and serves approximately 41 million U.S. employees and their dependents. MetLife has offered group vision insurance since 2012 and with the addition of Versant Health will serve roughly 38 million members.

“We are confident this acquisition will make our market-leading group benefits business even more attractive,” Ramy Tadros, President of U.S. Business for MetLife, said in the news release. “The addition of the strong Davis Vision and Superior Vision brands will immediately establish MetLife as a leader in managed vision care. We look forward to offering our customers the exceptional member experiences that Versant provides.”

This transaction is targeted to close in the fourth quarter of this year, subject to customary closing conditions, including regulatory approvals.

Transaction Highlights

Transaction

  • Acquiring 100% of Versant Health from private investor group
  • Purchase price of $1.675 billion in cash

Strong
Strategic Fit

  • Adds established product to our industry leading Group Benefits platform
  • MetLife will become 3rd largest U.S. vision insurer by membership
  • Meaningful revenue synergies with MetLife

Attractive
Financially

  • Expected to be accretive to EPS* and free cash flow
  • High teens expected internal rate of return
  • Low capital intensity and predictable underwriting

Financing

  • Cash on hand
  • Expect to complete current buyback authorization by year-end 2020

Timing

  • Targeted to close in Q4 2020
  • Subject to regulatory approvals and other closing conditions

* Adjusted earnings per common share.

 

Register

We're glad to see you're enjoying Modern Optometry…
but how about a more personalized experience?

Register for free